Stereotaxis, Inc.
General ticker "STXS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $204.0M (TTM average)
Stereotaxis, Inc. follows the US Stock Market performance with the rate: 60.8%.
Estimated limits based on current volatility of 2.7%: low 2.28$, high 2.43$
Factors to consider:
- Total employees count: 139 (+13.9%) as of 2024
- US accounted for 49.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Insufficient cash flow, Hospital purchasing decisions, Supply chain disruptions, Regulatory and compliance, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.50$, 3.03$]
- 2025-12-31 to 2026-12-31 estimated range: [1.50$, 3.05$]
Financial Metrics affecting the STXS estimates:
- Positive: with PPE of -7.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -4.30 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 18.93 < Shareholder equity ratio, % of 24.47 <= 41.86
- Negative: negative Net income
- Positive: Inventory ratio change, % of -0.87 <= -0.75
Short-term STXS quotes
Long-term STXS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $28.15MM | $26.77MM | $26.92MM |
| Operating Expenses | $46.92MM | $48.61MM | $51.66MM |
| Operating Income | $-18.78MM | $-21.84MM | $-24.74MM |
| Non-Operating Income | $0.48MM | $1.13MM | $0.69MM |
| R&D Expense | $10.56MM | $10.27MM | $9.76MM |
| Income(Loss) | $-18.29MM | $-20.71MM | $-24.05MM |
| Profit(Loss)* | $-18.29MM | $-20.71MM | $-24.05MM |
| Stockholders Equity | $26.35MM | $21.92MM | $11.43MM |
| Inventory | $7.88MM | $8.43MM | $8.33MM |
| Assets | $53.41MM | $41.91MM | $46.72MM |
| Operating Cash Flow | $-8.41MM | $-9.14MM | $-8.50MM |
| Capital expenditure | $2.38MM | $0.37MM | $0.03MM |
| Investing Cash Flow | $-22.09MM | $19.77MM | $0.07MM |
| Financing Cash Flow | $0.22MM | $0.08MM | $0.30MM |
| Earnings Per Share** | $-0.24 | $-0.26 | $-0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.